TG6002

AXP000094.1 · Oncolytic virus

Platform
vaccinia virus (Copenhagen, TK- RR-)
Originator
Transgene
Sponsor
Transgene

Names

NameTypeSource
TG6002preferred name, codecurator, ncit
T601codencit
TG6002/5-FCsynonymctgov

Virus

Role
Oncolytic
Family
Poxviridae
Virus
vaccinia virus (NCBI Taxonomy 10245)
Strain
Copenhagen
Replication
conditionally replicating
Modifications
J2R (thymidine kinase) and I4L (ribonucleotide reductase large subunit) deleted
Transgenes
FCU1
Route
intravenous, intratumoral, intra arterial
Source
evidence

Cross-references

NCI Thesaurus
C148178

Approvals

No regulatory approval recorded.

Clinical trials (4)

TrialTitleStatusPhaseStartPrimary completionEnrolmentConditions
NCT04194034Study of Intrahepatic Arterial Infusion of TG6002 in Combination With 5-FC in Patients With Metastatic Colorectal CancerTerminatedPhase 1/22020-01-172023-02-2315Colorectal Neoplasms
NCT04226066Safety, Tolerability and Pharmacokinetics Characteristics of Recombinant Oncolytic Vaccinia Virus Injection T601 as a Single Drug or in Combination With Oral Flucytosine (5-FC), in Patients With Advanced Malignant Solid TumorsUnknownPhase 1/22019-11-202021-05-3169Advanced Malignant Solid Tumors
NCT03724071Study of TG6002 (VV TK-RR-FCU1) in Combination With 5-FC in Patients With Advanced Gastro-intestinal Tumors.TerminatedPhase 1/22018-10-162023-02-2351Colorectal Neoplasm; Digestive System Neoplasm
NCT03294486Safety and Efficacy of the ONCOlytic VIRus Armed for Local Chemotherapy, TG6002/5-FC, in Recurrent Glioblastoma PatientsUnknownPhase 1/22017-10-122019-0578Brain Cancer; Glioblastoma

Recent changes

No changes recorded in its trials yet.

Clinical papers

PubMedTitleJournalYearLinked by
PMID 39785814A Phase I Clinical Trial of Intrahepatic Artery Delivery of TG6002 in Combination with Oral 5-Fluorocytosine in Patients with Liver-Dominant Metastatic Colorectal Cancer.Clinical cancer research : an official journal of the American Association for Cancer Research2025name in title: TG6002

Other papers

Preclinical studies, reviews and other papers that name it.

PubMedTitleJournalYearLinked by
PMID 41070126TG6002 oncolytic vaccinia virus and chemotherapy synergy: a promising strategy for pancreatic ductal adenocarcinoma.Frontiers in microbiology2025name in title: TG6002
PMID 38806994A viral attack on brain tumors: the potential of oncolytic virus therapy.Journal of neurovirology2024name in abstract: TG6002
PMID 37635744Oncolytic virotherapy with intratumoral injection of vaccinia virus TG6002 and 5-fluorocytosine administration in dogs with malignant tumors.Molecular therapy oncolytics2023name in title: TG6002
PMID 34004331Oncolytic viruses as a promising therapeutic strategy against the detrimental health impacts of air pollution: The case of glioblastoma multiforme.Seminars in cancer biology2022name in abstract: TG6002
PMID 34915313T598 and T601 phosphorylation sites of canine parvovirus NS1 are crucial for viral replication and pathogenicity.Veterinary microbiology2022name in title: T601
PMID 33500518Safety, biodistribution and viral shedding of oncolytic vaccinia virus TG6002 administered intravenously in healthy beagle dogs.Scientific reports2021name in title: TG6002
PMID 32843040Safety studies and viral shedding of intramuscular administration of oncolytic vaccinia virus TG6002 in healthy beagle dogs.BMC veterinary research2020name in title: TG6002
PMID 33072863Preclinical Evaluation of the Oncolytic Vaccinia Virus TG6002 by Translational Research on Canine Breast Cancer.Molecular therapy oncolytics2020name in title: TG6002
PMID 31011628The Enhanced Tumor Specificity of TG6002, an Armed Oncolytic Vaccinia Virus Deleted in Two Genes Involved in Nucleotide Metabolism.Molecular therapy oncolytics2019name in title: TG6002
PMID 28496337Immunogenicity of oncolytic vaccinia viruses JX-GFP and TG6002 in a human melanoma in vitro model: studying immunogenic cell death, dendritic cell maturation and interaction with cytotoxic T lymphocytes.OncoTargets and therapy2017name in title: TG6002
Unconfirmed matches (11)

Found by a weaker match (an ambiguous or short name, or a name only in the abstract); not counted. Corrections welcome.

PubMedTitleJournalYearLinked by
PMID 32060423PLK1/NF-κB feedforward circuit antagonizes the mono-ADP-ribosyltransferase activity of PARP10 and facilitates HCC progression.Oncogene2020name in abstract: T601
PMID 25982914Genotype-specific prevalence of heterogeneous vancomycin-intermediate Staphylococcus aureus in Asian countries.International journal of antimicrobial agents2015name in abstract: T601
PMID 23118474Phenotypic and molecular characterization of Staphylococcus aureus recovered from different clinical specimens of inpatients at a teaching hospital in Shanghai between 2005 and 2010.Journal of medical microbiology2013name in abstract: T601
PMID 21239868Distribution of virulence genes in spa types of methicillin-resistant Staphylococcus aureus isolated from patients in intensive care units.The Korean journal of laboratory medicine2011name in abstract: T601
PMID 20510060[Research on genotyping of methicillin-resistant Staphylococcus aureus in China.].Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi2010name in abstract: T601
PMID 19685173Mutagenesis and cysteine scanning of transmembrane domain 10 of the human dipeptide transporter.Pharmaceutical research2009name in abstract: T601
PMID 8407585Studies on cell growth stimulating substances of low molecular weight. Part 2. Exfoliazone and lavanducyanin, potent growth promoting substances of rat liver cell line, RLN-8, produced by Streptomyces exfoliatus and Streptomyces aeriouvifer.The Journal of antibiotics1993name in abstract: T601
PMID 3032185Conservation of E6 and E7 regions of human papillomavirus types 16 and 18 present in cervical cancers.Biochemical and biophysical research communications1987name in abstract: T601
PMID 6181731Correlation between D region structure and antigen-binding specificity: evidences from the comparison of closely related immunoglobulin VH sequences.Annales d'immunologie1981name in abstract: T601
PMID 6772205A common mechanism of hapten binding to immunoglobulins and their heterologous chain recombinants.Biochemistry1980name in abstract: T601
PMID 804990A new, mouse-myeloma immunoglobulin A having specificity for beta-D-(1 yields 6)-linked D-galactopyranosyl residues.Carbohydrate research1975name in abstract: T601

Notes

Armed with the yeast FCU1 gene, used with oral flucytosine. Licensed to Tasly Biopharmaceuticals for China, where it is called T601 (NCIt lists T601 as a synonym of TG6002), so T601 is recorded here as the same program and not a separate one.

How to cite

TG6002 (AXP000094.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000094.html

Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.